Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

JFL Life Sciences

₹40.6 0 | 0%

Market Cap ₹45 Cr.

Stock P/E 0.0

P/B 1.4

Current Price ₹40.6

Book Value ₹ 29.3

Face Value 10

52W High ₹56

Dividend Yield 0%

52W Low ₹ 36.1

JFL Life Sciences Research see more...

Overview Inc. Year: 2010Industry: Pharmaceuticals & Drugs

JFL Life Sciences Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

JFL Life Sciences Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

JFL Life Sciences Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 32 30 33 34 43
Other Income 0 0 0 1 2
Total Income 32 30 33 34 44
Total Expenditure 30 28 31 28 39
Operating Profit 1 2 2 6 6
Interest 1 1 1 2 1
Depreciation 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 0 0 1 4 4
Provision for Tax 0 0 0 1 1
Profit After Tax 0 0 1 3 3
Adjustments 0 0 0 0 0
Profit After Adjustments 0 0 1 3 3
Adjusted Earnings Per Share 0.6 0.7 0.8 3.5 2.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 26% 13% 0% 0%
Operating Profit CAGR 0% 44% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -11% NA% NA% NA%
ROE Average 13% 18% 13% 13%
ROCE Average 15% 16% 14% 14%

JFL Life Sciences Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 5 5 7 11 32
Minority's Interest 0 0 0 0 0
Borrowings 3 1 8 8 1
Other Non-Current Liabilities 0 0 0 0 0
Total Current Liabilities 8 18 14 28 15
Total Liabilities 16 24 29 48 49
Fixed Assets 2 5 7 7 7
Other Non-Current Assets 0 1 2 2 1
Total Current Assets 14 18 20 39 41
Total Assets 16 24 29 48 49

JFL Life Sciences Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0
Cash Flow from Operating Activities -3 3 -6 2 -9
Cash Flow from Investing Activities -1 -3 -2 -1 1
Cash Flow from Financing Activities 4 -0 7 -1 8
Net Cash Inflow / Outflow -0 0 -0 0 -0
Closing Cash & Cash Equivalent 0 0 0 0 0

JFL Life Sciences Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.55 0.66 0.84 3.5 2.55
CEPS(Rs) 0.83 1.09 1.27 3.97 2.95
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) 9.12 9.78 10.64 14.08 29.34
Core EBITDA Margin(%) 4.16 6.17 6.6 15.96 9.18
EBIT Margin(%) 3.68 5.5 6.04 17.51 12
Pre Tax Margin(%) 1.33 1.65 2.28 11.31 8.69
PAT Margin (%) 0.95 1.19 1.65 8.37 6.56
Cash Profit Margin (%) 1.44 1.98 2.5 9.47 7.56
ROA(%) 1.87 1.78 2.03 7.27 5.77
ROE(%) 6.03 6.94 8.85 30.94 12.9
ROCE(%) 8.71 11.8 10.32 23.14 15.44
Receivable days 110.94 135 136.23 171.72 180.11
Inventory Days 19.61 33.01 52.81 112.44 117.95
Payable days 17.75 70.61 84.51 141.53 120.24
PER(x) 0 0 0 0 12.92
Price/Book(x) 0 0 0 0 1.12
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.28 0.31 0.53 0.7 1.01
EV/Core EBITDA(x) 6.65 4.98 7.66 3.79 7.8
Net Sales Growth(%) 0 -5.06 8.63 2.49 27.51
EBIT Growth(%) 0 41.97 19.38 196.94 -12.59
PAT Growth(%) 0 19.14 50.42 418.35 0
EPS Growth(%) 0 19.14 27.99 317.59 -27.09
Debt/Equity(x) 1.68 1.73 2.45 1.4 0.22
Current Ratio(x) 1.67 1.05 1.49 1.38 2.7
Quick Ratio(x) 1.46 0.84 1.07 0.86 1.87
Interest Cover(x) 1.57 1.43 1.61 2.83 3.62
Total Debt/Mcap(x) 0 0 0 0 0.2

JFL Life Sciences Shareholding Pattern

# Sep 2022 Dec 2022 Mar 2023 Sep 2023 Mar 2024
Promoter 67.47 67.47 67.47 67.47 67.47
FII 0 0 0 0 0
DII 0 0 0 0 0
Public 32.53 32.53 32.53 32.53 32.53
Others 0 0 0 0 0
Total 100 100 100 100 100

Pros

  • Debtor days have improved from 141.53 to 120.24days.
  • Company has reduced debt.
  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

JFL Life Sciences News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....